Advertisement
U.S. markets open in 4 hours 47 minutes

Acorda Therapeutics, Inc. (ACOR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
13.01-0.59 (-4.34%)
At close: 03:54PM EST
12.66 -0.35 (-2.69%)
Pre-Market: 04:09AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close13.60
Open14.02
Bid0.00 x 1100
Ask0.00 x 1200
Day's Range13.01 - 14.72
52 Week Range9.00 - 24.20
Volume10,943
Avg. Volume4,276
Market Cap17.638M
Beta (5Y Monthly)1.42
PE Ratio (TTM)5.44
EPS (TTM)2.39
Earnings DateMar 07, 2024 - Mar 11, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ACOR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Acorda Therapeutics, Inc.
    ACOR: Lowering target price to $15.00ACORDA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $15.00; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    6 years agoArgus Research
View more